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Compound Heterozygous Mutations Including a De
Novo Missense Mutation in ABCA12 Led to a Case of
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Daisuke Sawamura1, Hironori Niizeki3, Sachiko Miyagawa3 and Hiroshi Shimizu1
Harlequin ichthyosis (HI) is one of the most devastating genodermatoses. Recently, ABCA12 mutations were
identified as the cause of HI. A newborn Japanese male demonstrated the typical features of HI. The patient was
treated with oral etretinate and his general condition has been good (now aged 1.5 years). This patient with
moderate clinical severity was compound heterozygous for a novel de novo missense mutation 1160G4A
(S387N) in exon 10 and a maternal deletion mutation 4158_4160delTAC (T1387del) in exon 28 of ABCA12.
T1387del was a deletion of a highly conserved threonine residue within the first adenosine 50 triphosphate-
binding domain and is thought to seriously affect the function of the ABCA12 protein. Conversely, the residue
387 is located outside the known active sites of ABCA12 and S387N is predicted not to lead to a serious
functional deficiency in ABCA12. Electron microscopy revealed abnormal lamellar granules in the granular
layer cells and a moderate number of lipid vacuoles in the cornified cells. Disturbed glucosylceramide transport
was confirmed in the cultured keratinocytes from the patient. No de novo mutation in ABCA12 has yet
been reported either in HI or lamellar ichthyosis. The present case suggested that a de novo ABCA12 mutation
might underlie HI.
Journal of Investigative Dermatology (2006) 126, 1518–1523. doi:10.1038/sj.jid.5700295; published online 4 May 2006
INTRODUCTION
Harlequin ichthyosis (HI) (MIM no. 242500) is a severe and
often fatal congenital ichthyosis with an autosomal recessive
inheritance pattern (Williams and Elias, 1987; Akiyama,
1999; Judge et al., 2004).
In 2005, ABCA12 mutations were identified in HI families
(Akiyama et al., 2005; Kelsell et al., 2005). The pathomechani-
sms of HI became known when functional defects in the lipid
transporter ABCA12 were shown to cause abnormal lipid
transport via lamellar granules (LGs) in the keratinocytes,
resulting in malformation of the patient’s intercellular lipid
layers of the stratum corneum (Akiyama et al., 2005). However,
genotype/phenotype correlations in HI cases with ABCA12
mutations have yet to be fully elucidated (Akiyama, in press a).
In the study of this case, we have found a compound
heterozygous ABCA12 combination of mutations, a novel de
novo missense mutation, S387N, in exon 10 and a maternal
deletion mutation T1387del in exon 28 in a newborn HI
baby. In the majority of HI patients, deletion or truncation
mutations seriously affecting ABCA12 function were found.
However, in the present case, one mutation was a missense
mutation located in the cytoplasmic region of ABCA12
polypeptide, not in the transmembrane domain or the
adenosine 50 triphosphate (ATP)-binding cassettes. The nature
and site of mutations might be the key to the relatively
moderate phenotype of this HI patient.
In addition, the novel mutation S387N was the first
reported de novo mutation in ABCA12. Our case suggested
the possibility that de novo mutations can cause the
occurrence of HI in non-consanguineous families.
RESULTS
Clinico-pathological features of the patient
The patient was a newborn Japanese male. He was born at 33
weeks and 3 days pregnancy by premature, vaginal delivery
(body weight 1,876 g). He was the first child of non-
consanguineous healthy parents. There was no family history
of congenital ichthyosis. At birth, the patient had presented
with severe hyperkeratosis over his entire body, severe
ectropion, eclabium, and malformed pinnae (Figure 1).
The patient’s clinical features at birth were characteristic of
typical HI. He was admitted into a neonatal intensive care
unit and had oral etretinate treatment (1 mg/kg/day). At this
time, light microscopy of the lesional skin sample from the
patient’s trunk showed marked hyperkeratosis with only a
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small number of parakeratotic cells. At the age of 1 year, the
patient showed dark brownish, thick scales over the entire
body surface including the face, palms, and the soles.
ABCA12 mutation analysis
Mutation analysis of the 53 exons including the intron–exon
boundaries of the entire ABCA12 gene revealed a 1160G4A
transition in exon 10 and one previously reported deletion
mutation 4158_4160delTAC in exon 28 in each allele in a
compound heterozygous fashion in the patient (sequence
according to Lefe`vre et al. (2003)) (GenBank accession NM
173076) (Figure 2). The mutation 1160G4A transition was a
novel missense mutation that changed a serine residue of
codon 387 to an asparagine residue (S387N). This missense
mutation S387N was not found in either in the parent’s (father
or mother), although the patient’s mother was heterozygous
for the deletion mutation 4158_4160delTAC (Figure 2). Thus,
the missense mutation S387N was thought to be a de novo
mutation and the deletion mutation was a maternal mutation.
Paternity testing by microsatellite marker analysis proved the
father was the patient’s true genetic father (data not shown).
These mutations were not found in 200 normal, unrelated
Japanese alleles (100 normal unrelated Japanese individuals)
by sequence analysis, and were unlikely to be a polymorphism
(data not shown). The deletion mutation 4158_4160delTAC
led to an in-frame deletion of a highly conserved threonine
residue at codon 1387 (T1387del) within the first ATP-binding
domain of ABCA12. Thus, the deletion mutation is thought to
seriously affect either the function or specific critical structures
of the ABCA12 protein (Akiyama et al., 2005).
Ultrastructure of the patient’s skin
Electron microscopy revealed that, in the keratinocyte
cytoplasm of the granular layer, no normal LGs were
apparent. Lipid droplets, vacuoles, and multivesiculated
bodies were seen in keratinocytes in the keratinized and
granular cell layers (Figure 3a and b). The number of
abnormal lipid droplets in the keratinized stratum corneum
cells was smaller than that in skin samples from HI patients
harboring the homozygous splice acceptor site mutation
IVS23-2A4G of ABCA12 (Akiyama et al., 2005) (Figure 3c),
although the number of lipid vacuoles was larger than those
in lamellar ichthyosis patients with ABCA12 mutations (data
not shown). Cornified cell envelope formation was normal in
the granular and cornified layer cells (Figure 3h).
Distribution of ABCA12 and glucosylceramide in patient’s skin
Immunofluorescence studies revealed that ABCA12 was
positive in the upper epidermal layers, mainly in the granular
layers, of normal human skin (Figure 4c). In the epidermis of
the present patient, reduced ABCA12 immunostaining was
seen in the upper epidermis (Figure 4a), compared with
seriously reduced immunolabeling in epidermal keratino-
cytes from the HI patient harboring a homozygous splice
acceptor site mutation IVS23-2A4G (Figure 4b) (Akiyama
et al., 2005). These findings confirmed that the present
patient expresses a significant amount of mutated ABCA12
protein in his epidermis.
Immunofluorescent staining showed that glucosylcer-
amide, a major lipid component of LGs (Vielhaber et al.,
2001; Ishida-Yamamoto et al., 2004) and an essential
component of the epidermal permeability barrier (Holleran
et al., 1993), was sparsely distributed in the patient’s upper
epidermis (Figure 4a), compared with a restricted, intense
distribution in the granular layers of normal skin (Figure 4c).
The condensed glucosylceramide staining was not seen in the
patient’s granular layers (Figure 4a).
Figure 1. The patient showed a typical clinical phenotype of HI in the
neonatal period. The entire body surface was covered with thick plate-like
scales and fissures.
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Figure 2. Compound heterozygous mutations of ABCA12 in the patient.
(a) Direct sequencing revealed a heterozygous 1160G4A transition (a
missense mutation S387N) in exon 10 of ABCA12 of the patient, but not in his
parents or normal control samples. (b) A heterozygous deletion mutation
4158_4160delTAC (T1387del) was found in exon 28 of ABCA12 of the
patient and his mother, but not in his father or in normal controls.
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Abnormal glucosylceramide transport in patient’s cultured
keratinocytes
Culture of the patient’s keratinocytes under high-Ca2þ
conditions (2.0 mM) induced a large number of cells to
express condensed glucosylceramide staining around the
nuclei, and this glucosylceramide failed to become localized
to the periphery of the keratinocyte cytoplasm (Figure 5a).
Culture of normal human keratinocytes in high-Ca2þ
conditions exhibited a more diffuse glucosylceramide stain-
ing throughout the cytoplasm (Figure 5b).
DISCUSSION
The ATP-binding cassette (ABC) transporter superfamily is
one of the largest gene families, encoding a highly conserved
group of proteins involved in energy-dependent active
transport (Higgins, 1992; Allikmets et al., 1996; Dean et al.,
2001; Borst and Elferink, 2002) and, recently, this super-
family has been highlighted in the dermatology fields (Uitto,
2005). The ABCA subfamily is suggested to work in lipid
transport (Weng et al., 1999; Hayden et al., 2000; Orso et al.,
2000; Schmitz and Langmann, 2001; Peelman et al., 2003)
and has received considerable attention (Klein et al., 1999)
because mutations in these genes have been implicated in
several human genetic diseases (Allikmets et al., 1997a, b;
Brooks-Wilson et al., 1999; Rust et al., 1999; Oram, 2002).
Keratinocyte LGs are known lipid-transporting organelles and
LG contents are secreted into the intercellular space, forming
an intercellular lipid layer between the granular layer cells
and keratinized cells in the stratum corneum. Our previous
study (Akiyama et al., 2005) has clearly demonstrated that
ABCA12 functions in the transport of endogenous lipid to the
keratinocyte cell periphery via LGs.
The abnormal LGs in the granular layer keratinocytes and
a lack of extracellular lipid lamellae reflect the defective lipid
transport via LGs and the malformation of intercellular
stratum corneum lipid layer in HI (Akiyama, in press a). In
2005, ABCA12 mutations that seriously affect its function
were shown to cause a loss of the skin lipid barrier, leading to
HI (Akiyama et al., 2005). In addition to HI with defective
lipid layers in the stratum corneum, ichthyosis syndromes are
also thought to share similar pathomechanisms (Akiyama, in
press b). For example, Dorfman–Chanarin syndrome (neutral




Figure 3. Abnormal LGs in the granular layer cells and accumulation of lipid
droplets in the stratum corneum cells of the patient’s epidermis.
(a) Abnormal LGs in the granular layer cells of the patient. (b) Abnormal lipid
droplets accumulated in the cornified cells in the patient’s epidermis,
although the numbers and amounts of lipid droplets was smaller than that
seen in an HI patient harboring a homozygous splice acceptor site mutation
IVS23-2A4G of ABCA12 (c). (d) No lipid droplets were observed in control
normal human stratum corneum cells. (a, b) the present patient; (c) control
typical HI patient reported previously (Akiyama et al., 2005); (d) normal
control human skin. (e) Cornified cell envelope (arrows) with normal
thickness was seen in the cornified layer cells in the present HI patient. Inset:
the cornifed layer cell of the control lamellar ichthyosis patient with
transglutaminase 1 gene mutations showed malformed, thin cornified cell
envelope (arrowheads). Bars¼ 200 nm.
a b c
Figure 4. Abnormal ABCA12 immunostaining and disturbed distribution
of glucosylceramide in the patient’s epidermis. (a) In the patient’s upper
epidermis, weak ABCA12 immunostaining (red: arrows) was diffusely seen in
the keratinocyte cytoplasm. Glucosylceramide labeling (green: arrowheads)
was also diffusely observed in the keratinocytes of upper epidermis. (b) In the
control HI patient carrying a homozygous splice acceptor site mutation
IVS23-2A4G of ABCA12, ABCA12 immunolabeling (red) was very weak,
although diffuse glucosylceramide immunolabeling (green: arrowheads) was
seen in the keratinocyte cytoplasm of upper epidermis. (c) In normal control
human epidermis, both ABCA12 (red) and glucosylceramide (green) labelings
overlapped, resulting in a yellow color in the granular layer (arrows). Dotted
line; granular layer–cornified layer interface. ABCA12, tetramethylrhodamine
isothiocyanate (red); glucosylceramide, FITC (green); nuclear staining,
TO-PRO (blue). Bar¼ 10mm.
a b
Figure 5. Altered glucosylceramide distribution in the patient’s
cultured keratinocytes. (a) In keratinocytes cultured from the patient,
glucosylceramide labeling (green) was observed mainly in the perinuclear
area of cytoplasm, suggesting disturbed glucosylceramide transport. (b) In
normal cultured human keratinocytes, glucosylceramide (green) was seen
diffusely in the cytoplasm to the cell periphery. Glucosylceramide, FITC
(green); nuclear staining, propidium idodide (red). Bar¼10 mm.
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defective lipid production in LGs caused by a deficiency in
the CGI-58 protein that is thought to be involved in the
pathogenesis of this form of ichthyosis (Akiyama et al., 2003).
In Sjo¨gren–Larsson syndrome harboring fatty aldehyde
dehydrogenase (FALDH) gene (ALDH3A2) mutations, defec-
tive LG formation was reported as one sign of a putative
pathogenetic mechanism (Shibaki et al., 2004). Recently,
mutations in a new gene, FLJ39501, encoding a cytochrome
P450, family 4, subfamily F, polypeptide 2 homolog of the
leukotriene B4-o-hydroxylase (CYP4F2) were reported to
underlie lamellar ichthyosis cases linked to chromosome
19p12–q12 (Lefe`vre et al., 2006). These facts further support
the idea that abnormal LG lipid contents and defective
intercellular lipid are prevailing concepts of pathogenetic
mechanisms in the ichthyoses.
In the present case based on the reported amino-acid
sequence (Annilo et al., 2002), the deletion mutation
4158_4160delTAC led to an in-frame deletion of a threonine
residue at codon 1387 (T1387del) within the first ATP-
binding domain of ABCA12 protein (Figure 6). This threonine
residue is a highly conserved residue between diverse species
and is thought to be important in the function of ABCA12
(Akiyama et al., 2005). Indeed, a compound heterozygous
patient with this deletion mutation and a separate ABCA12
truncation mutation was previously reported as a typical HI
newborn who died 15 days after birth (Akiyama et al., 2005).
The novel de novo mutation S387N in the present patient
is located outside all of the known ABCA12 active transporter
sites, within the cytoplasmic domain at N-terminus of
ABCA12 polypeptide (Figure 6). Both serine and asparagine
are neutral amino acids with small side chains and this
missense mutation would be expected to not significantly
affect the conformation of ABCA12 molecule. Thus, one
would predict the de novo missense mutation S387N not to
lead to a serious ABCA12 functional loss. Considering
the nature and site of the ABCA12 mutations in this case,
we suggest that a combination of the deletion mutation and
the missense mutation leads to the current patient’s HI
phenotype with a moderate clinical severity.
In type 2 lamellar ichthyosis, a relatively mild form of
congenital ichthyosis, all five reported ABCA12 mutations
were missense mutations that resulted in only one amino-
acid alteration (Lefe`vre et al., 2003). Conversely, in our
previous study on HI families, no ABCA12 missense
mutations were identified and most of the defects led to
severe truncation of ABCA12 peptide, affecting important
nucleotide-binding fold domains and/or transmembrane
domains (Akiyama et al., 2005). The other, non-truncation
mutations in HI were deletion mutations affecting highly
conserved ABCA12 sequences (Akiyama et al., 2005). Thus,
it was thought that only truncation or deletion mutations in
conserved regions, which seriously affect the function of the
ABCA12 transporter protein, can lead to the HI phenotype.
In an additional series of HI patients, most ABCA12
mutations were homozygous truncation mutations (Kelsell
et al., 2005). Only one mutation in one HI patient was a
missense mutation and the patient was heterozygous for a
truncation mutation and the missense mutation.
Recently, the prognosis of newborns affected with HI has
improved, owing to better targeted oral retinoid treatment.
More than half of HI newborns including cases with a serious
functional loss of ABCA12 survive beyond the perinatal
period (Akiyama et al., 2005; Akiyama, in press a). Thus, it is
difficult to discuss genotype/phenotype correlations and
quality of life prognosis for ABCA12 mutations in HI.
Most families with HI or lamellar ichthyosis caused by
ABCA12 mutations were consanguineous and, in those
families, causative ABCA12 mutations were homozygous
mutations inherited with an autosomal recessive trait. No de
novo mutation has yet been reported in ABCA12, as far as we
know (Lefe`vre et al., 2003; Akiyama et al., 2005; Kelsell
et al., 2005). The present novel missense mutation S387N in
our case was the first de novo mutation reported in ABCA12.
The genetic information of whether the causative mutations
are inherited or de novo is very important for genetic
counseling in severe genetic disorders such as HI. Indeed,
in the present family, the parents had requested a prenatal
diagnosis of HI for their subsequent pregnancy. However, we
have demonstrated that the missense mutation was a de novo
mutation and that the patient’s father was not a carrier of any
ABCA12 mutation. Thus, the family could be spared of
the worry of an unnecessary HI prenatal diagnosis for the
subsequent pregnancy almost, although we cannot comple-
tely exclude the possibility that the father has a mosaic
mutation affecting his germ line. The present case suggested
that, in non-consanguineous HI families, a de novo ABCA12
mutation might be one source of mutations and underlines
that the detection of causative ABCA12 mutations is essential
for the genetic counseling for HI.
MATERIALS AND METHODS
Mutation detection
Mutational analysis was performed in the affected baby and the
parents. Briefly, genomic DNA isolated from peripheral blood was




























Figure 6. Schematic sequential arrangement of the domain structures of
ABCA12 protein and the position of mutations in the present HI patient.
Mutations in the present HI patient are marked by red arrows. Note that the de
novo missense mutation S387N is located in the intracytoplasmic region
between the N-terminus and the first transmembrane domain, not in any
active sites, and the other, deletion mutation T1387del is within the first ATP-
binding cassette, which is thought to be important for ABCA12 lipid
transporter activity.
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sequencing using an ABI PRISM 3100 genetic analyzer (ABI
Advanced Biotechnologies, Columbia, MD). Oligonucleotide pri-
mers and PCR conditions used for amplification of all exons 1–53 of
ABCA12 were originally derived from the report by Lefe`vre et al.
(2003) and were partially modified for the present study. The entire
coding region including the exon/intron boundaries for both forward
and reverse strands from the patient, family members, and 100
healthy Japanese controls were sequenced. No mutations were
found in 200 normal alleles from the healthy Japanese population.
Paternity testing was carried out using 16 microsatellite markers.
The parents provided informed consent to the experiments. The
experiments received institutional approval and the protocol
adhered to The Declaration of Helsinki Principles.
Ultrastructural observations
Skin biopsy samples were fixed in 5% glutaraldehyde solution, post-
fixed in 1% OsO4, dehydrated, and embedded in Epon 812. The
samples were sectioned at 1mm thickness for light microscopy and
thin sectioned for electron microscopy (70 nm thick). The thin
sections were stained with uranyl acetate and lead citrate and
examined in a transmission electron microscope. As controls,
lesional skin samles from lamellar ichthyosis patients with transglu-
taminase 1 gene mutations (Akiyama et al., 2001) or ABCA12
mutations were also studied.
Cell culture
A skin sample from the patient was processed for primary
keratinocyte culture, and cells were grown according to standard
procedures in defined keratinocyte serum-free medium (Invitrogen
Corp., Carlsbad, CA). After several passages in low-Ca2þ (0.09 mM)
conditions, cultures were grown in high-Ca2þ (2.0 mM) conditions.
Antibodies
Polyclonal anti-ABCA12 antiserum was raised in rabbits using a 14
amino-acid sequence synthetic peptide (residues 2567–2580)
derived from the ABCA12 sequence (NM 173076) as the immuno-
gen (Akiyama et al., 2005). The other primary antibody was mouse
monoclonal anti-glucosylceramide antibody (Alexis Biochemicals,
Lausanne, Switzerland).
Immunofluorescent labeling
Immunofluorescent labeling was performed as previously described
(Akiyama et al., 2000). Briefly, 6-mm-thick sections of fresh patient’s
skin was cut using a cryostat. The sections were incubated in primary
antibody solution for 1 hour at 371C. Antibody dilutions were as
follows; 1/10 for anti-ABCA12 antiserum and 1/10 for anti-
glucosylceramide antibody. The sections were then incubated in
FITC-conjugated to rabbit anti-mouse Igs and tetramethylrhodamine
isothiocyanate-conjugated goat anti-rabbit Igs diluted 1:100 (DAKO,
Glostrup, Denmark) for 30 minutes at room temperature, followed
by nuclear counterstain by TO-PRO-3 (Invitrogen, Carlsbad, CA).
The sections were extensively washed with phosphate-buffered
saline between incubations. The stained sections were then mounted
with a cover slip and observed using a confocal laser scanning
microscope.
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